Company Quick10K Filing
Apex 2
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.49 10 $5
10-Q 2019-03-31 Quarter: 2019-03-31
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-K 2013-12-31 Annual: 2013-12-31

Apex 2 Financials

-

APEX Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Burzynski Research Institute (BZYR) 5,258 13 213 0 0 0 0 5,255
Sci Engineered Materials (SCIA) 10,472 8,241 4,340 13,728 3,044 831 862 8,674
Drone Guarder (DRNG) 516 2,174 0 0 -2,096 -1,964 312
Thunder Mountain Gold (THMG) 4,210 2,340 1,720 1,554 0 971 971 4,059
Thunder Energies (TNRG) 0 3 794 0 0 -1,356 -1,353 -26
Giga Tronics (GIGA) 7,851 7,899 5,974 0 4,947 -741 -323 8,314
US Rare Earth Minerals (USMN) 5,108 45 702 0 0 -617 -592 5,696
Regen Biopharma (RGBP) 0 44 8,866 155 0 -883 -615 927
Patriot Gold (PGOL) 3,714 1,706 233 0 0 0 0 3,601
Imaging3 (IGNG) 809 14 5,324 5 5 -1,357 -537 2,961
Apex 2 (APEX) 5,204 20 230 0 0 -62 -62 5,184
Mentor Capital (MNTR) 7,636 5,658 2,021 5,140 1,539 -2,977 -2,907 6,537
RespireRx Pharmaceuticals (RSPI) 4,840 150 6,767 0 0 -2,227 -2,021 5,262
Acura Pharmaceuticals (ACUR) 1,480 2,152 5,769 525 0 -3,136 -2,857 5,613
STR Holdings (STRI) 4,433 22,829 6,387 0 -2,910 -8,438 -9,407 4,738
Two Hands (TWOH) 13,791 165 1,541 0 0 -9,796 -9,795 13,762
Andrea Electronics (ANDR) 4,086 1,518 2,212 1,950 1,340 -624 -527 5,419
Empire Petroleum (EMPR) 3,576 11,766 12,693 2,753 0 -3,134 -3,263 10,156
Innovus Pharmaceuticals (INNV) 3,584 10,837 10,791 12,211 8,077 -8,358 -6,105 5,144
Pressure Biosciences (PBIO) 6,122 2,240 10,423 2,237 863 -10,008 -6,440 6,004

Balance Sheet ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Cash000000000000000020202020202020202020202020
Accounts Receivable
Inventory
PP&E
Assets0000000000000000020202020202020202020202020
Accounts Payable155004222030413222268228
Long-Term Debt
Liabilities23681217192227323639424246495156587388105117129141168182196211230
Stockholders' Equity-2-3-6-8-12-17-19-23-27-32-36-39-42-42-46-49-51-36-39-53-68-85-97-109-121-148-163-177-192-211
Income Statement ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Revenue000
Cost of Revenue
Gross Profit
R&D
SG&A
Tax0000000000000000000000000
Net Income-1-3-2-5-2-3-4-5-4-3-20-4-3-2-5-3-14-15-17-12-12-12-27-14-14-15-19
Cash Flow ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Cash Operating-1-3-4-1-3-8-4-2-6-5-100-5-1-6-15-12-18-12-12-12-23-13-20-15-13
Cash Investing00
Cash Financing134138426510605206151218122313201513